{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:06:54Z","timestamp":1774282014124,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.autneu.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T16:03:58Z","timestamp":1509120238000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Symptomatic therapy of multiple system atrophy"],"prefix":"10.1016","volume":"211","author":[{"given":"Guido","family":"Rohrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2017.10.006_bb0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mds.20450","article-title":"Depressive symptoms and life satisfaction in patients with multiple system atrophy","volume":"20","author":"Benrud-Larson","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0010","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"114.04035","author":"Biaggioni","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2017.10.006_bb0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.72.3.300","article-title":"Dystonia in multiple system atrophy","volume":"72","author":"Boesch","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2017.10.006_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002826-199408000-00010","article-title":"Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration","volume":"17","author":"Bordet","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-199502000-00012","article-title":"Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration","volume":"18","author":"Bordet","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jnnp.52.8.962","article-title":"The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine","volume":"52","author":"Brooks","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2017.10.006_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3171\/jns.2004.100.3.0553","article-title":"Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy: case report","volume":"100","author":"Chou","year":"2004","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.autneu.2017.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00702-005-0379-0","article-title":"Management of multiple system atrophy: state of the art","volume":"112","author":"Colosimo","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.autneu.2017.10.006_bb0045","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/mds.21578","article-title":"Levodopa responsiveness in disorders with parkinsonism: a review of the literature","volume":"22","author":"Constantinescu","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.25407","article-title":"Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease","volume":"28","author":"Dams","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00415-006-0425-3","article-title":"Effects of daily water drinking on orthostatic and postprandial hypotension in patients with multiple system atrophy","volume":"254","author":"Deguchi","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0060","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A randomized trial of deep-brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0065","article-title":"Livedo reticularis in multiple system atrophy: case report","volume":"50","author":"Dutra","year":"2014","journal-title":"Rev. Bras. Neurol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5664\/jcsm.6068","article-title":"Alternatives to clonazepam in REM behavior disorder treatment","volume":"12","author":"Escriba","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mdc3.12270","article-title":"Elastic abdominal binders attenuate orthostatic hypotension in Parkinson's disease","volume":"3","author":"Fanciulli","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.autneu.2017.10.006_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756285610375328","article-title":"Multiple system atrophy: current and future approaches to management","volume":"3","author":"Flabeau","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0090","doi-asserted-by":"crossref","first-page":"iv27","DOI":"10.1136\/jnnp.74.suppl_4.iv27","article-title":"Investigation and management of neurogenic bladder dysfunction","volume":"74","author":"Fowler","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2017.10.006_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.parkreldis.2006.04.002","article-title":"Paroxetine treatment improves motor symptoms in patients with multiple system atrophy","volume":"12","author":"Friess","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5664\/jcsm.5500","article-title":"Central apneas and REM sleep behavior disorder as an initial presentation of multiple system atrophy","volume":"12","author":"Garcia-Sanchez","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.sleep.2004.10.002","article-title":"Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance","volume":"6","author":"Ghorayeb","year":"2005","journal-title":"Sleep Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.juro.2009.06.023","article-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy","volume":"182","author":"Giannantoni","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2017.10.006_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","article-title":"Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone","volume":"232","author":"Harkel","year":"1992","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0130","first-page":"511","article-title":"ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 2 study): interim results of an open-label safety study","volume":"7","author":"Hauser","year":"2017","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.autneu.2017.10.006_bb0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autneu.2017.10.006_bb0140","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0b013e3181c33adf","article-title":"Intensive coordinative training improves motor performance in degenerative cerebellar disease","volume":"73","author":"Ilg","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2017.10.006_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12311-013-0531-6","article-title":"Consensus paper: management of degenerative cerebellar disorders. The","volume":"13","author":"Ilg","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.autneu.2017.10.006_bb0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11940-007-0020-7","article-title":"Sleep and breathing in multiple system atrophy","volume":"9","author":"Iranzo","year":"2007","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.WNL.0000137043.76383.A4","article-title":"Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy","volume":"63","author":"Iranzo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2017.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/mds.20211","article-title":"Occupational therapy in multiple system atrophy: a pilot randomized controlled trial","volume":"19","author":"Jain","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0170","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.autneu.2017.10.006_bb0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2017.10.006_bb0180","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.autneu.2017.10.006_bb0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1756287213510962","article-title":"Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice","volume":"6","author":"Knuepfer","year":"2014","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.26874","article-title":"Profile of cognitive impairment and underlying pathology in multiple system atrophy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0195","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry","volume":"25","author":"K\u00f6llensperger","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0200","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1468-1331.2006.01512.x","article-title":"EFNS guidelines on the diagnosis and management of orthostatic hypotension","volume":"13","author":"Lahrmann","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/NPT.0b013e3181b511f4","article-title":"Challenge-oriented gait and balance training in sporadic olivopontocerebellar atrophy: a case study","volume":"33","author":"Landers","year":"2009","journal-title":"J. Neurol. Phys. Ther."},{"key":"10.1016\/j.autneu.2017.10.006_bb0210","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.autneu.2017.10.006_bb0215","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/mds.20108","article-title":"Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report","volume":"19","author":"Lezcano","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0220","series-title":"Botulinum Toxin Bladder Injection in the Treatment of Neurogenic Detrusor Overactivity and Idiopathic OAB, Functional Urologic Surgery in Neurogenic and Oncologic Diseases","first-page":"171","author":"Marzi","year":"2016"},{"key":"10.1016\/j.autneu.2017.10.006_bb0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.293.6543.353","article-title":"The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure","volume":"293","author":"Mathias","year":"1986","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.autneu.2017.10.006_bb0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2016.01.005","article-title":"Outcome of deep brain stimulation in slowly progressive multiple system atrophy: a clinico-pathological series and review of the literature","volume":"24","author":"Meissner","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.04.014","article-title":"Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients","volume":"32","author":"Moghadam","year":"2017","journal-title":"Sleep Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s004150200009","article-title":"Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia","volume":"249","author":"M\u00fcller","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.03.008","article-title":"Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy","volume":"247","author":"Nonaka","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.autneu.2017.10.006_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1353-8020(97)00022-9","article-title":"Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy","volume":"3","author":"Rajrut","year":"1997","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/neup.12381","article-title":"Perirhinal accumulation of neuronal alpha-synuclein in a multiple system atrophy patient with dementia","volume":"37","author":"Saito","year":"2017","journal-title":"Neuropathology"},{"key":"10.1016\/j.autneu.2017.10.006_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-1838(99)00105-8","article-title":"Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy?: a comparison of prazosin and moxisylyte","volume":"79","author":"Sakakibara","year":"2000","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.autneu.2017.10.006_bb0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10286-003-0052-3","article-title":"The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria","volume":"13","author":"Sakakibara","year":"2003","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2017.10.006_bb0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy\u2014a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med."},{"key":"10.1016\/j.autneu.2017.10.006_bb0275","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.21428","article-title":"Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease","volume":"22","author":"Schoffer","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0280","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mds.20808","article-title":"Health-related quality of life in multiple system atrophy","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0285","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.22794","article-title":"A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy","volume":"25","author":"Schrag","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.genhosppsych.2005.08.003","article-title":"Electroconvulsive therapy for the treatment of multiple system atrophy with major depression","volume":"28","author":"Shioda","year":"2006","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.autneu.2017.10.006_bb0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0300","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.27018","article-title":"REM sleep behavior disorder in Parkinson's disease and other synucleinopathies","volume":"32","author":"St Louis","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0305","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0310","series-title":"Depression and Anxiety in Parkinson's Disease and Multiple System Atrophy-Consequences for Treatment","author":"Strand","year":"2016"},{"key":"10.1016\/j.autneu.2017.10.006_bb0315","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mds.1101","article-title":"Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy","volume":"16","author":"Thobois","year":"2001","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.autneu.2017.10.006_bb0320","article-title":"Physiotherapy versus placebo or no intervention in Parkinson's disease","author":"Tomlinson","year":"2013","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.autneu.2017.10.006_bb0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1519\/00139143-200831020-00007","article-title":"The impact of resistance training on balance and functional ability of a patient with multiple system atrophy","volume":"31","author":"Wedge","year":"2008","journal-title":"J. Geriatr. Phys. Ther."},{"key":"10.1016\/j.autneu.2017.10.006_bb0330","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.autneu.2017.10.006_bb0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0340","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0345","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1002\/mds.20543","article-title":"Therapeutic strategies in multiple system atrophy","volume":"20","author":"Wenning","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.autneu.2017.10.006_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.wnf.0000183240.47960.f0","article-title":"Placebo-controlled trial of amantadine in multiple-system atrophy","volume":"28","author":"Wenning","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.autneu.2017.10.006_bb0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070217301637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070217301637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:11:54Z","timestamp":1761567114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070217301637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":71,"alternative-id":["S1566070217301637"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2017.10.006","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic therapy of multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}